Bret Jensen
Bret Jensen is the lead equities analyst with Investors Alley. He's the editor of their newsletters including The Growth Stock Advisor and Biotech Gems.
Bret Jensen's Latest Posts
4 Undervalued Stocks To Buy And 5 Overvalued Stocks To Sell
Now that we’re at the half point of 2016, Bret Jensen identifies the best and worst areas to put your money for the rest of the year. Plus Bret gives you his favorite stocks in each of those sectors along with five stocks facing significant headwinds. It is hard to believe we are already in […]
7 Undervalued Stocks To Buy And 3 To Sell
The market is once again approaching fairly valued, however, some stocks still trade at compelling levels while others are overvalued and should be sold. Where you invest your funds and, even more importantly, where you do not will be critical to beating the market in 2016. The S&P 500 is approaching 52-week highs again and […]
Biotech Is Back: Why The 15% Rally Is For Real
After falling over 40% in six months, the biotech sector has soared 15% in just the last two weeks. The sector remains oversold, creating very appealing entry points. These four companies are Bret Jensen’s favorites to continue the rally. After spending over six months deep in the doldrums, and in the deepest and longest bear […]
Your Portfolio Is Missing This Safe And Growing Stock
It will easily outperform the market in 2016 and if you buy in today you will be able to participate in years of growing shareholder value from this tech behemoth. If you do not have this stock in your portfolio you are making a big mistake. Alphabet (NASDAQ: GOOGL) the new holding company for Google reported after […]